No abstract available
Publication types
-
Comment
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Carotid Artery Injuries / pathology
-
Cell Division
-
Clinical Trials as Topic
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / adverse effects*
-
Cyclooxygenase Inhibitors / pharmacology
-
Cyclooxygenase Inhibitors / therapeutic use
-
Epoprostenol / metabolism*
-
Homeostasis
-
Humans
-
Isoenzymes / antagonists & inhibitors
-
Lactones / adverse effects*
-
Lactones / pharmacology
-
Lactones / therapeutic use
-
Membrane Proteins
-
Mice
-
Muscle, Smooth, Vascular / cytology
-
Myocardial Infarction / epidemiology
-
Naproxen / therapeutic use
-
Platelet Activation / drug effects*
-
Prostaglandin-Endoperoxide Synthases
-
Receptors, Epoprostenol
-
Receptors, Prostaglandin / genetics
-
Receptors, Prostaglandin / metabolism
-
Receptors, Thromboxane / genetics
-
Receptors, Thromboxane / metabolism
-
Sulfones
-
Thromboxane A2 / metabolism*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoenzymes
-
Lactones
-
Membrane Proteins
-
Receptors, Epoprostenol
-
Receptors, Prostaglandin
-
Receptors, Thromboxane
-
Sulfones
-
rofecoxib
-
Thromboxane A2
-
Naproxen
-
Epoprostenol
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
PTGS1 protein, human
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Ptgs1 protein, mouse